Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeff Eidel

Pacific Biosciences Of California, Inc. reported in an 8-K filed November 12, 2024 that Jeff Eidel was terminated as Chief Commercial Officer, effective November 15, 2024. The proxy statement of Pacific Biosciences Of California, Inc. reports total compensation of $3,333,167 for Jeff Eidel in fiscal 2024, including a base salary of $420,208. Disclosed compensation is on record for 3 fiscal years.

“On November 11, 2024, Pacific Biosciences of California, Inc. (the “Company”) notified Jeff Eidel that, in connection with an internal restructuring of the commercial organization, he would separate from his position as the Chief Commercial Officer on November 15, 2024.”
Pacific Biosciences Of California, Inc. Form 8-K, filed November 12, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Pacific Biosciences Of California, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Pacific Biosciences Of California, Inc. (PACB) $420,208 $3,333,167
2023 Pacific Biosciences Of California, Inc. (PACB) $456,333 $2,533,727
2022 Pacific Biosciences Of California, Inc. (PACB) $164,250 $5,801,485

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.